<<Prev Rule

Texas Administrative Code

Next Rule>>
TITLE 22EXAMINING BOARDS
PART 15TEXAS STATE BOARD OF PHARMACY
CHAPTER 291PHARMACIES
SUBCHAPTER ECLINIC PHARMACY (CLASS D)
RULE §291.93Operational Standards

(a) Registration.

  (1) Licensing requirements.

    (A) All clinic pharmacies shall register with the board on a pharmacy license application provided by the board, following the procedures specified in §291.1 of this title (relating to Pharmacy License Application).

    (B) All clinic pharmacies shall provide a copy of their policy and procedure manual, which includes the formulary, to the board with the initial license application.

    (C) The following fees will be charged.

      (i) A fee as specified in §291.6 of this title (relating to Pharmacy License Fees) will be charged for the issuance of a new license and for each renewal.

      (ii) A pharmacy operated by the state or a local government that qualifies for a Class D license is not required to pay a fee to obtain a license.

    (D) A Class D pharmacy which changes ownership shall notify the board within ten days of the change of ownership and apply for a new and separate license as specified in §291.3 of this title (relating to Required Notifications).

    (E) A clinic pharmacy shall notify the board in writing of any change in name or location as specified in §291.3 of this title.

    (F) A separate license is required for each principal place of business and only one pharmacy license may be issued to a specific location.

    (G) A clinic pharmacy shall notify the board in writing within 10 days of a change of the pharmacist-in-charge or staff pharmacist or consultant pharmacist.

    (H) A Class D pharmacy shall notify the board in writing within ten days of closing, following the procedures as specified in §291.5 of this title (relating to Closing a Pharmacy).

  (2) Registration requirements for facilities that operate at temporary clinic sites. A facility that operates a clinic at one or more temporary locations may be licensed as a Class D pharmacy and provide dangerous drugs from these temporary locations provided:

    (A) the Class D pharmacy complies with the registration requirements in paragraph (1) of this subsection;

    (B) the Class D pharmacy has a permanent location where all dangerous drugs and records are stored;

    (C) no dangerous drugs are stored or left for later pickup by the patient at the temporary location(s), and all drugs are returned to the permanent location each day and stored:

      (i) within the Class D pharmacy; or

      (ii) within the pharmacy's mobile unit provided the mobile clinic is parked at the location of the clinic pharmacy in a secure area with adequate measures to prevent unauthorized access, and the drugs are maintained at proper temperatures;

    (D) the permanent location is the address of record for the pharmacy;

    (E) the facility has no more than six temporary locations in operation simultaneously;

    (F) the Class D pharmacy notifies the board of the locations of the temporary locations where drugs will be provided and the schedule for operation of such clinics; and

    (G) the Class D pharmacy notifies the board within 10 days of a change in address or closing of a temporary location or a change in schedule of operation of a clinic.

(b) Environment.

  (1) General requirements.

    (A) The Class D pharmacy shall have a designated area(s) for the storage of dangerous drugs and/or devices.

    (B) No person may operate a pharmacy which is unclean, unsanitary, or under any condition which endangers the health, safety, or welfare of the public.

    (C) The Class D pharmacy shall comply with all federal, state, and local health laws and ordinances.

    (D) A sink with hot and cold running water shall be available to all pharmacy personnel and shall be maintained in a sanitary condition at all times.

  (2) Security.

    (A) Only authorized personnel may have access to storage areas for dangerous drugs and/or devices.

    (B) All storage areas for dangerous drugs and/or devices shall be locked by key, combination, or other mechanical or electronic means, so as to prohibit access by unauthorized individuals.

    (C) The pharmacist-in-charge shall be responsible for the security of all storage areas for dangerous drugs and/or devices including provisions for adequate safeguards against theft or diversion of dangerous drugs and devices, and records for such drugs and devices.

    (D) The pharmacist-in-charge shall consult with clinic personnel with respect to security of the pharmacy, including provisions for adequate safeguards against theft or diversion of dangerous drugs and/or devices, and records for such drugs and/or devices.

    (E) Housekeeping and maintenance duties shall be carried out in the pharmacy, while the pharmacist-in-charge, consultant pharmacist, staff pharmacist, or supportive personnel is on the premises.

(c) Equipment. Each Class D pharmacy shall maintain the following equipment and supplies:

  (1) if the Class D pharmacy prepackages drugs for provision:

    (A) a typewriter or comparable equipment; and

    (B) an adequate supply of child-resistant, moisture-proof, and light-proof containers and prescription, poison, and other applicable identification labels used in dispensing and providing of drugs;

  (2) if the Class D pharmacy maintains dangerous drugs requiring refrigeration and/or freezing, a refrigerator and/or freezer;

  (3) if the Class D pharmacy compounds prescription drug orders, a properly maintained Class A prescription balance (with weights) or equivalent analytical balance. It is the responsibility of the pharmacist-in-charge to have such balance inspected at least every three years by the appropriate authority as prescribed by local, state, or federal law or regulations.

(d) Library. A reference library shall be maintained which includes the following in hard copy or electronic format:

  (1) current copies of the following:

    (A) Texas Pharmacy Act and rules; and

    (B) Texas Dangerous Drug Act;

  (2) current copies of at least two of the following references:

    (A) Facts and Comparisons with current supplements;

    (B) AHFS Drug Information;

    (C) United States Pharmacopeia Dispensing Information (USPDI);

    (D) Physician's Desk Reference (PDR);

    (E) American Drug Index;

    (F) a reference text on drug interactions, such as Drug Interaction Facts. A separate reference is not required if other references maintained by the pharmacy contain drug interaction information including information needed to determine severity or significance of the interaction and appropriate recommendations or actions to be taken;

    (G) reference texts in any of the following subjects: toxicology, pharmacology, or drug interactions; or

    (H) reference texts pertinent to the major function(s) of the clinic.

(e) Drugs and devices.

  (1) Formulary.

    (A) Each Class D pharmacy shall have a formulary which lists all drugs and devices that are administered, dispensed, or provided by the Class D pharmacy.

    (B) The formulary shall be limited to the following types of drugs and devices, exclusive of injectable drugs for administration in the clinic and nonprescription drugs, except as provided in subparagraph (D) of this paragraph:

      (i) anti-infective drugs;

      (ii) musculoskeletal drugs;

      (iii) vitamins;

      (iv) obstetrical and gynecological drugs and devices;

      (v) topical drugs; and

      (vi) serums, toxoids, and vaccines.

    (C) The formulary shall not contain the following drugs or types of drugs:

      (i) Nalbuphine (Nubain);

      (ii) drugs used to treat erectile dysfunction; and

      (iii) Schedule I - V controlled substances.

    (D) Clinics with a patient population which consists of at least 80% indigent patients may petition the board to operate with a formulary which includes types of drugs and devices, other than those listed in subparagraph (B) of this paragraph based upon documented objectives of the clinic, under the following conditions.

      (i) Such petition shall contain an affidavit with the notarized signatures of the medical director, the pharmacist-in-charge, and the owner/chief executive officer of the clinic, and include the following documentation:

        (I) the objectives of the clinic;

        (II) the total number of patients served by the clinic during the previous fiscal year or calendar year;

Cont'd...

Next Page

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page